Impact of Chemotherapy-Induced Peripheral Neuropathy on Quality of Life in Patients with Advanced Lung Cancer Receiving Platinum-Based Chemotherapy

Impact of Chemotherapy-Induced Peripheral Neuropathy on Quality of Life in Patients with Advanced Lung Cancer Receiving Platinum-Based Chemotherapy

Chemotherapy-induced peripheral neuropathy (CIPN) is a common adverse effect of neurotoxic anticancer drugs that may affect quality of life (QoL). Purpose: The purposes of this study were to: assess the levels of CIPN, anxiety, depression, CIPN–related QoL, and general QoL; and identify the factors...

Full description

Bibliographic Details
Main Authors:	Hsing-Wei Hung, Chien-Ying Liu, Hsiu-Fang Chen, Chun-Chu Chang, Shu-Ching Chen
Format:	Article
Language:	English
Published:	MDPI AG 2021-05-01
Series:	International Journal of Environmental Research and Public Health
Subjects:	lung cancer chemotherapy cisplatin carboplatin chemotherapy-induced peripheral neuropathy quality of life
Online Access:	https://www.mdpi.com/1660-4601/18/11/5677

Similar Items

Risk factors for chemotherapy‐induced peripheral neuropathy in patients receiving taxane‐ and platinum‐based chemotherapy
by: Alex Molassiotis, et al.
Published: (2019-06-01)

Treatment strategies for chemotherapy-induced peripheral neuropathy: potential role of exercise
by: Karen Y. Wonders, et al.
Published: (2011-12-01)

Falls and Functional Impairments in Breast Cancer Patients with Chemotherapy-Induced Peripheral Neuropathy
by: Hiroko Komatsu, et al.
Published: (2019-01-01)

The Role of Nucleotide Excision Repair in Cisplatin-Induced Peripheral Neuropathy: Mechanism, Prevention, and Treatment
by: Scarlett Acklin, et al.
Published: (2021-02-01)

Therapeutic Effects of Phytochemicals and Medicinal Herbs on Chemotherapy-Induced Peripheral Neuropathy
by: Gihyun Lee, et al.
Published: (2016-09-01)

Rolapitant for the prevention of nausea in patients receiving highly or moderately emetogenic chemotherapy
by: Rudolph M. Navari, et al.
Published: (2018-07-01)

New Insights into Potential Prevention and Management Options for Chemotherapy-Induced Peripheral Neuropathy
by: Janet Schloss, et al.
Published: (2016-01-01)

Chemotherapy-Induced Peripheral Neuropathy and Physiotherapy
by: Gro S. Haugen, et al.
Published: (2013-04-01)

Chemotherapy for small cell lung cancer: a comprehensive review
by: Syed Mustafa Karim, et al.
Published: (2012-04-01)

Physiotherapy management of chemotherapy-induced peripheral neuropathy in Pretoria, South Africa
by: Esther A. Niemand, et al.
Published: (2020-10-01)

Characteristics and Quality of Life in Gynecologic Cancer Patients with Chemotherapy-induced Peripheral Neuropathy
by: Ju Hyeon Jeong, et al.
Published: (2013-12-01)

Modulation by Ozone Therapy of Oxidative Stress in Chemotherapy-Induced Peripheral Neuropathy: The Background for a Randomized Clinical Trial
by: Bernardino Clavo, et al.
Published: (2021-03-01)

Emerging Pharmacological and Non-Pharmacological Therapeutics for Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy
by: Yang Li, et al.
Published: (2021-02-01)

Pregabalin Attenuates Carboplatin-Induced Akathisia-Like Neuropathy: A Novel Case Report
by: Yoshitaka Saito, et al.
Published: (2021-10-01)

Drug Repositioning for the Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy: A Mechanism- and Screening-Based Strategy
by: Shota Yamamoto, et al.
Published: (2021-01-01)

Characterization of Internal Validity Threats to Phase III Clinical Trials for Chemotherapy-Induced Peripheral Neuropathy Management: A Systematic Review
by: Deborah Lee, et al.
Published: (2019-01-01)

Whole-body vibration as a modality for the rehabilitation of peripheral neuropathies: implications for cancer survivors suffering from chemotherapy-induced peripheral neuropathy
by: Anna L.J. Verhulst, et al.
Published: (2015-02-01)

Integrated Medicine for Chemotherapy-Induced Peripheral Neuropathy
by: Chih-Hung Tsai, et al.
Published: (2021-08-01)

Ten weeks of home-based exercise attenuates symptoms of chemotherapy-induced peripheral neuropathy in breast cancer patients
by: Karen Y. Wonders, et al.
Published: (2013-09-01)

Spinal Cord Stimulation as a Treatment Option for Refractory Chemotherapy-Induced Peripheral Neuropathy: Case Report
by: Arthur Lopes, et al.
Published: (2020-06-01)

Managing Chronic Kidney Disease and Chemotherapy-Induced Peripheral Neuropathy with Acupuncture and Herbal Medicine: A Case Study
by: Sunny-Kim Barden
Published: (2017-04-01)

Are we mis-estimating chemotherapy-induced peripheral neuropathy? Analysis of assessment methodologies from a prospective, multinational, longitudinal cohort study of patients receiving neurotoxic chemotherapy
by: Alex Molassiotis, et al.
Published: (2019-02-01)

Chemotherapy induced peripheral neuropathic pain
by: Hue Jung Park
Published: (2014-07-01)

Chemotherapy-induced-peripheral neuropathy, gait and fall risk in older adults following cancer treatment
by: Timothy F. Marshall, et al.
Published: (2017-12-01)

The effect of neoadjuvant platinum-based chemotherapy in BRCA mutated triple negative breast cancers -systematic review and meta-analysis
by: Olga Caramelo, et al.
Published: (2019-03-01)

Small extracellular vesicles ameliorate peripheral neuropathy and enhance chemotherapy of oxaliplatin on ovarian cancer
by: Yi Zhang, et al.
Published: (2021-03-01)

Early Onset of Platinum Hypersensitivity in a Dentist:A Case Report
by: Maurie Markman, et al.
Published: (2010-08-01)

Efficacy of Alpha Lipoic Acid Supplementation In Chemotherapy-Induced Peripheral Neuropathy
by: Mediarty Syahrir, et al.
Published: (2020-12-01)

Oxidative stress and nerve damage: Role in chemotherapy induced peripheral neuropathy
by: Aparna Areti, et al.
Published: (2014-01-01)

Neuroinflammatory Process Involved in Different Preclinical Models of Chemotherapy-Induced Peripheral Neuropathy
by: Giulia Fumagalli, et al.
Published: (2021-02-01)

The efficacy and safety of electro-acupuncture for alleviating chemotherapy-induced peripheral neuropathy in patients with coloreactal cancer: study protocol for a single-blinded, randomized sham-controlled trial
by: Kaiyin Chan, et al.
Published: (2020-01-01)

Assessing gait, balance, and muscle strength among breast cancer survivors with chemotherapy-induced peripheral neuropathy (CIPN): study protocol for a randomized controlled clinical trial
by: Adams, A., et al.
Published: (2022)

Regulatable Transgene Expression for Prevention of Chemotherapy-Induced Peripheral Neuropathy
by: Daisuke Kawata, et al.
Published: (2017-09-01)

Redefining chemotherapy-induced peripheral neuropathy through symptom cluster analysis and patient-reported outcome data over time
by: Mian Wang, et al.
Published: (2019-11-01)

Associations between self-reported diet during treatment and chemotherapy-induced peripheral neuropathy in a cooperative group trial (S0221)
by: Jennifer M. Mongiovi, et al.
Published: (2018-11-01)

Chemotherapy-Induced Peripheral Neuropathy and Changes in Cytoskeleton
by: Alessio Malacrida, et al.
Published: (2019-05-01)

Investigating the Role of Nicotinic Acetylcholine Receptor Agonists in Lung Cancer Progression and Chemosensitivity in the Context of Treating Chemotherapy-Induced Peripheral Neuropathy
by: Kyte, Sarah L
Published: (2018)

Potential mediators of improvement in painful chemotherapy-induced peripheral neuropathy via a web-based cognitive behavioural intervention
by: Robert Knoerl, et al.
Published: (2018-07-01)

Mechanisms of Chemotherapy-Induced Peripheral Neuropathy
by: Renata Zajączkowska, et al.
Published: (2019-03-01)

Role of HMGB1 in Chemotherapy-Induced Peripheral Neuropathy
by: Fumiko Sekiguchi, et al.
Published: (2021-12-01)